Ophthalmologic Drug Guide [electronic resource] /by Douglas J. Rhee, Kathryn A. Colby, Christopher J. Rapuano, Lucia Sobrin.
by Rhee, Douglas J [author.]; Colby, Kathryn A [author.]; Rapuano, Christopher J [author.]; Sobrin, Lucia [author.]; SpringerLink (Online service).
Material type:
BookPublisher: New York, NY : Springer New York, 2007.Description: XII, 142 p. online resource.ISBN: 9780387499642.Subject(s): Medicine | Ophthalmology | Medicine & Public Health | OphthalmologyDDC classification: 617.7 Online resources: Click here to access online | Item type | Current location | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|
| MAIN LIBRARY | RE1-994 (Browse shelf) | Available |
Browsing MAIN LIBRARY Shelves Close shelf browser
Antibacterial Agents -- Antifungal Agents -- Antiviral Agents -- Antiparasitic Agents -- Antiglaucoma Agents -- Neuro-Ophthalmology -- Anti-Inflammatory Agents -- Mydriatics, Cycloplegics, and Reversal Agents -- Lubricants and Viscoelastics -- Miscellaneous Conditions -- Anti-Angiogenesis Agents -- Contact Lens Solutions.
Ophthalmology has long been considered a surgical area because so many disorders/diseases are treated surgically rather than medically. In the past ten years, however, there have been considerable therapeutic breakthroughs in non-surgical treatments. For instance, anti-glaucoma agents have becoming increasingly effective. This edition will include a new chapter for retinal disease. There are now several pharmaceutical agents being used to treat these diseases. Specifically, age-related macular degeneration has many new products – macugen, lucentis, etc. – and intraocular infections are primarily treated with intravitreal medications. Additionally, the anti-allergy and dry eye markets have grown tremendously in the last 2-3 years (endura, restasis, xibrom, etc).
There are no comments for this item.